3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Small Cell Lung Carcinoma
19
Ovarian Neoplasms
17
Neuroblastoma
15
Fallopian Tube Neoplasms
13
Neoplasms
6
Carcinoma, Ovarian Epithelial
6
Ganglioneuroblastoma
5
Brain Neoplasms
4
Uterine Cervical Neoplasms
3
Recurrence
3
Neoplasm Metastasis
3
Lung Neoplasms
3
Glioma
3
Central Nervous System Neoplasms
3
Sarcoma, Ewing
2
Rhabdoid Tumor
2
Retinoblastoma
2
Medulloblastoma
2
Leukemia, Myeloid, Acute
2
Wilms Tumor
1
Thrombocythemia, Essential
1
SCLC, Extensive Stage
1
SCLC
1
Rhabdomyosarcoma
1
Retinal Neoplasms
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Pleuropulmonary blastoma
1
Peritoneal Neoplasms
1
Pediatric Brain Tumor
1
Interventions
Cytarabine
4
Azacitidine
4
venetoclax
3
Whole-Body Irradiation
3
Peripheral Blood Stem Cell Transplantation
3
Injections
3
Biopsy
3
pegylated granulocyte colony-stimulating factor
2
Tacrolimus
2
Mitoxantrone
2
Gemtuzumab
2
Decitabine
2
Daunorubicin
2
Cyclophosphamide
2
Cladribine
2
Busulfan
2
Bone Marrow Transplantation
2
ruxolitinib
1
fludarabine phosphate
1
fludarabine
1
fedratinib
1
enasidenib
1
aldesleukin
1
Thiotepa
1
Spinal Puncture
1
Specimen Handling
1
Social Determinants of Health
1
Sirolimus
1
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
1
Mycophenolic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Monocytic, Acute
×
Topotecan
×
1 year
×
Clear all
No trials found.